G&S Capital LLC Amgen Inc Transaction History

G&S Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $1.27 Million - $1.5 Million	5,912 New	5,912 $1.31 Million
Q1 2018 Apr 25, 2018	SELL	$169.43 - $198.0 $2.98 Million - $3.49 Million	-17,616 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $2.97 Million - $3.32 Million	17,616	17,616 $3.06 Million

3,173

419M

8.25M

6.39M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

Stay updated on G&S Capital LLC with notifications on news.